Month: March 2019

Dr. Raj Mehra Interview with Nicole Petallides of TD Ameritrade Network’s “The Watchlist”

Live from the Nasdaq market site, Nicole Petallides of TD Ameritrade Network’s “The Watchlist” interviewed Raj Mehra, PhD on Seelos Therapeutics’ pipeline developments and corporate highlights on March 25, 2019. Please follow this link for the archive of this interview: https://tdameritradenetwork.com/video/rB4AoWmoG5SBabX3gpQB8Q

Archive Webcast of Seelos Presentation at Cowen’s 39th Annual Health Care Conference

by Anthony Marciano On the morning of March 13, 2019 Dr. Raj Mehra presented at Cowen’s 39th Annual Health Care Conference in Boston, MA.  The webcast link for this archived presentation is located at: http://wsw.com/webcast/cowen52/seel/

Dr. Raj Mehra Interview with Proactive Investors

by Anthony Marciano On the morning of March 8, 2019 Dr. Raj Mehra was interviewed by Proactive Investors. Among the notable items in this video interview, Dr. Mehra shared how the company has acquired an exclusive license to the rights to a potential Parkinson’s disease therapy created by researchers at the University of California, Los…
Read more

Our Acquisition of a Disease-Modifying Parkinson’s Disease Therapy

by Anthony Marciano On March 07, 2019, Seelos Therapeutics, Inc. (Nasdaq: SEEL) announced it acquired an exclusive license to intellectual property owned by The Regents of the University of California (The UC Regents) pertaining to a technology that was created by researchers at the University of California, Los Angeles (UCLA). Such technology relates to a…
Read more